GNOM Stock Summary and Trading Ideas (Global X Genomics & Biotechnology ETF | NASDAQ:GNOM)

The Global X Genomics & Biotechnology ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index. The Solactive Genomics Index tracks the price movements in shares of companies which are active in the field of Genomics. These companies include those involved in the following business activities: gene editing, genomic sequencing, development and testing of genetic medicine or therapies, computational genomics and genetic diagnostics or biotechnology.

Global X Genomics & Biotechnology ETF trades on the NASDAQ stock market under the symbol GNOM.

As of December 11, 2024, GNOM stock price declined to $10.65 with 69,645 million shares trading.

GNOM has a beta of 1.45, meaning it tends to be more sensitive to market movements. GNOM has a correlation of 0.38 to the broad based SPY ETF.

GNOM has a market cap of $77.86 million. This is considered a Micro Cap stock.

In the last 3 years, GNOM traded as high as $20.70 and as low as $8.63.

GNOM has underperformed the market in the last year with a price return of +0.7% while the SPY ETF gained +33.5%. GNOM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -2.5% and +0.9%, respectively, while the SPY returned +11.0% and +1.1%, respectively.

GNOM support price is $10.57 and resistance is $10.98 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GNOM shares will trade within this expected range on the day.